ALDERLEY PARK VENTURES LIMITED - Profile & Financials

Accounts Submitted 19 Sept 2025

Confirmation Statement Submitted 28 Oct 2025

Net assets £3.44M £3.44M 2024 year on year

Total assets £3.45M £3.44M 2024 year on year

Total Liabilities £6.00K £5.89K 2024 year on year

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Biocity Pennyfoot Street Nottingham NG1 1GF

Credit Report

Discover ALDERLEY PARK VENTURES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£526.00k

Increased by £525.98k (+2504662%)

Net Assets

£3.44M

Increased by £3.44M (+107839%)

Total Liabilities

£6.00k

Increased by £5.89k (+5614%)

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Decreased by 3 (-100%)

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

2 active 3 resigned

Show resigned officers

						Status
Glenn Crocker	Director	British	England	61	31 Aug 2017	Active
Joanne Kelley	Director	British	England	66	4 Jul 2017	Active

Shareholders

Shareholders (0)

No shareholder data available

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Biocity Group Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Right To Appoint And Remove Directors

Astrazeneca Uk Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Significant Influence Or Control

See All Controllers

Group Structure

ASTRAZENECA UK LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

BIOCITY GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ASTRAZENECA INTERMEDIATE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

PIONEERING PARKS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

ASTRAZENECA PLC united kingdom

PIONEERING INVESTMENT HOLDCO LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent

WE ARE PIONEER GROUP LIMITED united kingdom

ALDERLEY PARK VENTURES LIMITED Current Company

EYVIVA THERAPEUTICS LTD united kingdom shares 25 to 50 percent, voting rights 25 to 50 percent

FAST BIOPHARMA LTD united kingdom shares 25 to 50 percent

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
5 Nov 2025	Officers	Change to director Dr Glenn Crocker on 2025-11-03	View(2 pages)
5 Nov 2025	Officers	Change to director Dr Glenn Crocker on 2025-11-04	View(2 pages)
4 Nov 2025	Officers	Change to director Dr Glenn Crocker on 2025-11-03	View(2 pages)
4 Nov 2025	Officers	Change to director Dr Glenn Crocker on 2025-10-23	View(2 pages)
28 Oct 2025	Confirmation Statement	Confirmation statement made on 2025-10-06 with no updates	View(3 pages)